Chémobiologie
Assay development
5-azadeoxycytidine
Prostate cancer
DNMT/HMT crosstalk
Drug discovery
DNA methylation
Cancer epigenetics
Bisulfi te conversion
Chemical tools
Dichapetalum eickii
DNA methyltransferase
Agents anticancéreux
3-nitroflavanones
Mollusks
Inhibiteurs
Dichapetalum ruhlandii
Dichapetalaceae
Cancer biology
Chromosomes
Drug therapy
Chemical biology
Disruptor of telomeric silencing 1-like DOT1L
Anticancer
Melanoma
Conjugated allyl amines
Ageing
Cell differentiation
Antiviraux et antibiotiques
DNMT inhibitors
Parasites
Drug design
Chemical probes
Inhibitors
Dammarane
Bisubstrate inhibitors
5-aza-2’-deoxycytidine
Adenine analogues
3-Hydroxypyrrole
Tumor suppressor
Malaria
Cancer
Invertebrates
Bisubstrate inhibitors histone methyltransferases Legionella pneumophila High Content Screening Epigenetics
Apoptosis
DNMT2
Epidrugs
Bactéries
Dichapetalum zenkeri
Bacteria
Cell cycle
COMBINE
Chromosome clusters
Bacterial infection
Dichapetalum leucosia
Definition
Allylation reactions
Adenine analogs
EZH2
Detection
Chromocenters
Embryonic Stem Cell
DNA methylation inhibitor
Protocadherin
Drug resistance
2-benzimidazol-2-yl alkanols
DAXX
Apoenzyme crystal structure
Antimalarial agents
DNA methyltransferase inhibitors
Epigenetics
Cytotoxicity
Bisubstrates
DNMT
Adénine
3-Hydroxythiophene
Maladies infectieuses
DNA methyltransferases
Epigenetic inheritance
Biomphalaria glabrata
Adenine
Histone methylation
DOT1L
Epimutation
DNA and histone methylation
Dichapetalum mombuttense
Virus
Chemical targeting
DNA
Antiviral and antibacterial agents
DNA damage
Artemisinin resistance
Age-related pathologies
3-D QSAR
HMT inhibitors
Chimie médicinale
5-aza-2'-deoxycytidine
2-benzimidazol-2-yl alkylamines
DNA hypermethylation
ChIP
Antimalarial
Medicinal chemistry
Business strategy in drug development
Aggressiveness
5-Methylcytosine
Anticancer therapy
DNMT inhibitor